Evidence map›Paper›PMID 25950007›Full record

ArticleJournal of diabetes research2015

A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes.

Anna Lih, Lorraine Pereira, Ramy H Bishay, Johnson Zang, Abdullah Omari, Evan Atlantis, Nic Kormas

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna LihDepartment of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
Lorraine PereiraDepartment of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
Ramy H BishayDepartment of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
Johnson ZangDepartment of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
Abdullah OmariUniversity of New South Wales Medical Program, University of New South Wales, Sydney, NSW 2052, Australia ; Department of Vascular Medicine, St. Vincent's Hospital, Darlinghurst, Sydney, NSW 2010, Australia.
Evan AtlantisSchool of Nursing and Midwifery, University of Western Sydney, Campbelltown, NSW 2560, Australia ; School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.ORCID 0000-0001-5877-6141
Nic KormasDepartment of Endocrinology & Metabolism, Concord Repatriation General Hospital, Rhodes, NSW 2139, Australia ; Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionObesity and diabetes are difficult to treat in public clinics. We sought to determine the effectiveness of the Metabolic Rehabilitation Program (MRP) in achieving long-term weight loss and improving glycaemic control versus "best practice" diabetes clinic (DC) in obese patients using a retrospective cohort study.

methodsPatients with diabetes and BMI > 30 kg/m(2) who attended the MRP, which consisted of supervised exercise and intense allied health integration, or the DC were selected. Primary outcomes were improvements in weight and glycaemia with secondary outcomes of improvements in blood pressure and lipid profile at 12 and 30 months.

resultsBaseline characteristics of both cohorts (40 MRP and 40 DC patients) were similar at baseline other than age (63 in MRP versus 68 years in DC, P = 0.002). At 12 months, MRP patients lost 7.65 ± 1.74 kg versus 1.76 ± 2.60 kg in the DC group (P < 0.0001) and 9.70 ± 2.13 kg versus 0.98 ± 2.65 kg at 30 months (P < 0.0001). Similarly, MRP patients had significant absolute reductions in %HbA1c at 30 months versus the DC group (-0.86 ± 0.31% versus 0.12% ± 0.33%, P < 0.038), with nonsignificant improvements in lipids and blood pressure in MRP patients.

conclusionFurther research is needed to establish the MRP as an effective strategy for achieving sustained weight loss and improving glycaemic control in obese patients with type 2 diabetes.

Indexed as

Diet, ReducingExercise TherapyAgedBlood GlucoseBlood PressureBody WeightDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsLipidsMaleMiddle AgedObesityRetrospective StudiesTreatment OutcomeBlood GlucoseHypoglycemic AgentsLipids

Identifiers

PMID25950007
PMCPMC4408626

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.